CN113549649B - Preparation method of ginsenoside F1 - Google Patents

Preparation method of ginsenoside F1 Download PDF

Info

Publication number
CN113549649B
CN113549649B CN202110895036.0A CN202110895036A CN113549649B CN 113549649 B CN113549649 B CN 113549649B CN 202110895036 A CN202110895036 A CN 202110895036A CN 113549649 B CN113549649 B CN 113549649B
Authority
CN
China
Prior art keywords
ginsenoside
gene
tobacco
ugtpn20
pndds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202110895036.0A
Other languages
Chinese (zh)
Other versions
CN113549649A (en
Inventor
葛锋
雷君
陈勤
王志龙
胡泽群
刘迪秋
崔秀明
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kunming University of Science and Technology
Original Assignee
Kunming University of Science and Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kunming University of Science and Technology filed Critical Kunming University of Science and Technology
Priority to CN202110895036.0A priority Critical patent/CN113549649B/en
Publication of CN113549649A publication Critical patent/CN113549649A/en
Application granted granted Critical
Publication of CN113549649B publication Critical patent/CN113549649B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8201Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
    • C12N15/8202Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation by biological means, e.g. cell mediated or natural vector
    • C12N15/8205Agrobacterium mediated transformation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1288Transferases for other substituted phosphate groups (2.7.8)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Nutrition Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)

Abstract

The invention discloses ginsenoside F1The method of preparing (1) is to use the genePnDDSP12HD6HAndUGTPn20simultaneously transferring into tobacco to obtain synthetic ginsenoside F1The transgenic tobacco of (1), wherein the genePnDDSThe nucleotide sequence of (A) is shown as SEQ ID NO. 1, geneP12HThe nucleotide sequence of (A) is shown as SEQ ID NO. 2, geneD6HThe nucleotide sequence of (A) is shown as SEQ ID NO. 3, geneUGTPn20The nucleotide sequence of (A) is shown as SEQ ID NO. 4; the experimental results show thatThe obtained transgenic tobacco plant can synthesize ginsenoside F1To make ginsenoside F1The method is more efficient and convenient, simple, easy to operate and suitable for large-scale production and market popularization and application, and the method is used for obtaining the ginsenoside F1Provides a new approach.

Description

Ginsenoside F1Preparation method of (1)
Technical Field
The invention belongs to the technical field of biological medicine preparation, and particularly relates to heterologous synthesis of ginsenoside F in tobacco1The method of (1).
Background
Panax plants have been used for the treatment of various diseases and improvement of physical functions, wherein triterpenoid saponins are main active ingredients of Panax plants. The triterpene saponin has various pharmacological effects of promoting cell proliferation, inhibiting apoptosis, inhibiting oxidative stress, resisting inflammation, increasing cell activity, etc., and can be used for protecting nerve cell, myocardial cell, liver cell, lung epithelial cell, etc.
Ginsenoside F1( ginsenoside F1 ) Is rare dammarane type triterpenoid saponin component in medicinal plants such as ginseng, pseudo-ginseng, American ginseng and the like, is protopanaxatriol type saponin generated by catalyzing PPT and glycosyl donor UDP-glucose (UDP-glucose) through UDP-glucosyltransferase, and has the effects of resisting tumors, aging, oxidation and the like. Ginsenoside F1Has strong inhibiting effect on proliferation and migration of skin cancer cell B16 and melanin production, and can protect human stratum corneum HaCaT from damage caused by ultraviolet rays. Despite ginsenoside F1Has important pharmacological activity, but has very low content in Panax medicinal materials, and the Panax species is perennial plant with long growth period, so that the ginsenoside F is obtained1Is not easy to obtain and expensive, and the development and the acquisition of the ginsenoside F are urgently needed1Novel methods and novel approaches.
Tobacco is a wide-range economic crop with mature cultivation technology, has abundant natural product synthesis systems in vivo, and has a mature transgenic technology system. Although tobacco may have the potential to synthesize natural compounds, the synthesis of ginsenoside F in tobacco has not been seen1And no synthesis including ginsenoside F is found in the tobacco genome1The complete pathway of dammarane type tetracyclic triterpene saponins in the tobacco plant indicates that the tobacco plant does not have the capability of synthesizing the saponins.
Disclosure of Invention
Aiming at the defects of the prior art, the invention provides ginsenoside F1The method comprises constructing and synthesizing ginsenoside F in tobacco1Thereby producing ginsenoside F in tobacco1The invention provides a method for obtaining ginsenoside F1The new approach of (1);
the method of the invention is to use the genePnDDSP12HD6HAndUGTPn20simultaneously transferring into tobacco to obtain synthetic ginsenoside F1The transgenic tobacco of (1), wherein said genePnDDSThe nucleotide sequence of (A) is shown as SEQ ID NO. 1, geneP12HThe nucleotide sequence of (A) is shown as SEQ ID NO. 2, geneD6HThe nucleotide sequence of (A) is shown as SEQ ID NO. 3, geneUGTPn20The nucleotide sequence of (A) is shown in SEQ ID NO. 4.
The purpose of the invention is realized by the following technical scheme:
(1) from notoginseng (A)Panaxnotoginseng) Extracting total RNA from root, reverse transcription synthesizing notoginseng cDNA, using the synthesized first strand cDNA as template, PCR amplifying notoginsenoside skeleton synthetase genePnDDSSkeleton-modified enzyme geneP12HSkeleton-modified enzyme geneD6HAnd a backbone-modifying enzyme geneUGTPn20The amplification primers were as follows:
PnDDS-Kpn I -F:5'-GGGTACCCCTGCAGATGTGGAAGCTGAA-3';
PnDDS-Pst I-R:5'-TGCACTGCAGTGCACCCGGGTTAAATTTTGAGCT-3';
P12H-Sac I-F:5'-CGAGCTCGATGGTGTTGTTTTTCTCCCTATCT-3';
P12H-Pst I -R:5'-TGCACTGCAGTGCATTAATTGTGGGGATGTAGATGAAT-3';
D6H-Sac I-F:5'-CGAGCTCATGGATCTCTTTATCTCATCTC-3';
D6H-BamH I-R:5'-CGCGGATCCCAAGGTGATAGACGAATAGG-3';
UGTPn20-EcoR I-F:5'-GGAATTCCATAAATCTGGGAAAGGG-3';
UGTPn20-Sac I–R:5'-CGAGCTCGCCAACAATAAAATCGTCACT-3';
(restriction sites corresponding to the respective primers are underlined)
(2) Respectively connecting the target fragments to pCAMBIA2300s plant expression vectors, and transforming agrobacterium; screening out positive monoclonal by PCR;
(3) infecting tobacco leaf with positive agrobacterium containing target gene, and regenerating plant to obtain tobacco leaf containing target genePnDDSP12HD6HAndUGTPn20transgenic tobacco plants of four genes;
(4) extracting total RNA from positive transgenic tobacco, performing reverse transcription to obtain cDNA, and performing RT-PCR to determine whether four genes are expressed;
(5) drying and grinding the leaves of the transgenic tobacco, soaking the leaves in methanol for 24 hours, then ultrasonically extracting saponin, and detecting the types and the content of the ginsenoside in the transgenic tobacco by using HPLC.
The invention has the advantages and technical effects that:
the invention is based on the characteristics of easy planting and rapid growth of tobacco, and separates the gene from notoginsengPnDDSP12HD6HAndUGTPn20simultaneously transferring into tobacco and obtaining the expression of the samePnDDSP12HD6HAndUGTPn20the experimental results of the four-gene transgenic tobacco show that the transgenic plant obtained by the invention canCan synthesize ginsenoside F1To make ginsenoside F1The method is simple, easy to operate and suitable for large-scale production and market popularization and application, and the method is used for obtaining the ginsenoside F1Provides a new approach.
Drawings
FIG. 1 shows genesPnDDSP12HD6HAndUGTPn20 detecting the electrophoresis detection result of the PCR product, wherein M is DNA Marker;
FIG. 2 is the identification electrophoretogram of four genes transferred into Agrobacterium LBA 4404;
wherein the A diagram is pCAMBIA2300s-DS(ii) a The B diagram is pCAMBIA2300s-P12H(ii) a The C diagram is pCAMBIA2300s-D6H(ii) a The diagram D is pCAMBIA2300s-UGTPn20In the figure, M is a DNA Marker, and 1-5 are positive agrobacterium strains; "-" is water as template; "+" is cDNA as template;
FIG. 3 is a PCR-verified electrophoresis of DNA in transgenic tobacco, wherein M is DNA Marker, WT is wild type tobacco, T1-T6 is transgenic tobacco, and "+" is cDNA as template;
FIG. 4 is a PCR-verified electrophoresis of cDNA in transgenic tobacco, wherein M is DNA Marker, WT is wild type tobacco, T1-T6 is transgenic tobacco, and "+" is cDNA as template;
FIG. 5 is a graph showing the saponin content in transgenic tobacco, wherein WT is wild type tobacco, T4-T5 is transgenic tobacco, DD is dammarenediol, PPD is protopanaxadiol, and PPT is protopanaxatriol.
Detailed Description
The present invention is further illustrated by the following examples, which are not intended to limit the scope of the present invention, and the methods used in the examples are all conventional methods unless otherwise specified, and reagents used therein are all conventional commercially available reagents or reagents prepared by conventional methods.
Example 1:PnDDSP12HD6HandUGTPn20cloning of genes
Grinding Notoginseng radix with liquid nitrogen into powder, transferring into centrifuge tube, extracting total RNA from Notoginseng radix root by guanidinium isothiocyanate method,the first strand cDNA is synthesized by reverse transcription, and the reaction system and the operation process are as follows: taking 5 μ g of Total RNA, adding 50ng oligo (dT), 2 μ L dNTP (2.5 mM each) and DEPC water in sequence to the reaction volume of 14.5 μ L; after mixing uniformly, heating and denaturing at 70 ℃ for 5min, then quickly cooling on ice for 5min, then sequentially adding 4 mu L of 5 XFirst-stand buffer, 0.5 mu LRNasin (200U) and 1 mu L M-MLV (200U), mixing uniformly and centrifuging for a short time, carrying out warm bath at 42 ℃ for 1.5h, taking out, heating at 70 ℃ for 10min, and terminating the reaction; amplifying ginsenoside F by PCR using the synthesized first strand cDNA as template1Four genes in the synthetic pathwayPnDDSP12HD6HAndUGTPn20using CE Design software to Design primers with homology arms, and the primers used for amplification are respectively as follows:
PnDDS-Kpn I -F:5'-GGGTACCCCTGCAGATGTGGAAGCTGAA-3';
PnDDS-Pst I-R:5'-TGCACTGCAGTGCACCCGGGTTAAATTTTGAGCT-3';
P12H-Sac I-F:5'-CGAGCTCGATGGTGTTGTTTTTCTCCCTATCT-3';
P12H-Pst I -R:5'-TGCACTGCAGTGCATTAATTGTGGGGATGTAGATGAAT-3';
D6H-Sac I-F:5'-CGAGCTCATGGATCTCTTTATCTCATCTC-3';
D6H-BamH I-R:5'-CGCGGATCCCAAGGTGATAGACGAATAGG-3';
UGTPn20-EcoR I-F:5'-GGAATTCCATAAATCTGGGAAAGGG-3';
UGTPn20-Sac I–R:5'-CGAGCTCGCCAACAATAAAATCGTCACT-3';
(restriction sites corresponding to the respective primers are underlined)
The PCR reaction system is 50 μ L and comprises: 25 μ L of LPrime STAR MAX Premix, 1 μ L of forward primer F, 1 μ L of reverse primer R1 μ L, 1 μ L of cDNA, 22 μ L of ddH2O; and (3) PCR reaction conditions: 3min at 98 ℃; 10 s at 98 ℃, 15 s at 60 ℃, 15 s at 72 ℃ and 35 cycles; 5min at 72 ℃; after PCR is finished, agarose gel electrophoresis detectionThe detection result is shown in figure 1, and the sizes of the four gene amplification bands are respectively as follows: 2310bp, 1503bp, 1407bp and 1423 bp. After successful amplification, the target band was recovered using a SanPrep column DNA gel recovery kit (Shanghai Biotech): taking 1 microliter of the recovered product, detecting the size and concentration of the recovered fragment by agarose gel electrophoresis, and storing at-20 ℃ for later use.
Example 2: plant expression vector construction
The plant expression vector pCAMBIA2300s was linearized with restriction enzymes, which were 15. mu.L pCAMBIA2300s plasmid, 5. mu.L 10 XM buffer, 2.5. mu.L each of enzymes at the front and rear cleavage sites, 25. mu.L ddH2O, mixing uniformly, centrifuging for a short time, and placing at 37 ℃ for enzyme digestion for 3.5 h; dropping the enzyme digestion product in agarose gel for electrophoresis, then carrying out gel recovery on the pCAMBIA2300s carrier large fragment, and using a SanPrep column type DNA gel recovery kit (Shanghai production) in the whole process; taking 1 microliter of the recovered product, detecting the size and concentration of the recovered fragment by agarose gel electrophoresis, and storing at-20 ℃ for later use. In the case of homologous recombination, the collected product is assembled using the Clonexpressing Multi S One Step Cloning KitPnDDSP12HD6HAndUGTPn20respectively connected to pCAMBIA2300s plant expression vector, reaction system (10 μ L) and operation process: 4 mu.L pCAMBIA2300S vector DNA, 2 mu.L target fragment, 2 mu.L 5 xcell buffer, and 1 mu. L, ddH of Exnase II2O1 mu L, mixing uniformly, centrifuging for a short time, and then carrying out water bath reaction at 37 ℃ for 30 min; then transferring the ligation product into escherichia coli DH5 alpha by adopting a heat shock transformation method, coating the escherichia coli DH5 alpha on an LB solid culture medium containing 50mg/L kanamycin, and culturing for 24h at 37 ℃; selecting single bacterial colony in LB liquid culture medium containing 50mg/L kanamycin, shaking bacteria at 37 ℃ and 200rpm, respectively carrying out PCR by using bacterial liquid as a template and using specific primers for amplifying four genes, respectively selecting clones of the four genes successfully connected with pCAMBIA2300s, if the detected bacterial strain is positive, sending the positive to a sequencing company for further final confirmation, and finally adding glycerol into the escherichia coli bacterial liquid containing the target gene and storing the escherichia coli bacterial liquid at-80 ℃ for later use.
Extraction of pCAMBIA2300 s-containing protein from Escherichia coli by using SanPrep column type plasmid DNA small extraction kitDS、pCAMBIA2300s-P12H、pCAMBIA2300s-D6HAnd pCAMBIA2300s-UGTPn20Plasmid is extracted according to the instruction of the kit; taking 1 μ L of the extract, detecting the size and concentration of the recovered fragment by agarose gel electrophoresis, and storing at-20 deg.C for use.
Example 3: agrobacterium-mediated genetic transformation of plants and transgenic plant screens
The plant expression vector pCAMBIA2300s constructed above is frozen and thawed by liquid nitrogenDS、pCAMBIA2300s-P12H、pCAMBIA2300s-D6HAnd pCAMBIA2300s-UGTPn20Transferring the agrobacterium tumefaciens LBA4404 competent cells into an agrobacterium tumefaciens LBA4404 competent cell, and comprising the following operation steps: adding 2 mu g of plasmid into a centrifuge tube containing 200 mu L of competent cells, gently mixing uniformly, performing ice bath for 5min, then transferring into liquid nitrogen for freezing for 1min, then rapidly placing in a 37 ℃ water bath for 5min, then immediately performing ice bath for 2min, adding 800 mu L of LB liquid culture medium, and performing shake culture at 28 ℃ and 200rpm for 4 h; coating the activated agrobacterium on LB solid culture medium containing 50mg/L kanamycin and 25mg/L rifampicin, and standing and culturing at 28 ℃ for about 48 h; selecting single colony shake bacteria, shake culturing in LB liquid culture medium containing 50mg/L kanamycin and 25mg/L rifampicin at 28 deg.C and 200rpm for 24h, finally performing PCR with specific primer for amplifying four genes to determine pCAMBIA2300s-DS、pCAMBIA2300s-P12H、pCAMBIA2300s-D6HAnd pCAMBIA2300s-UGTPn20The plasmid has been transformed into Agrobacterium; the results of PCR detection are shown in FIG. 2, and 5 strains of transgenic pCAMBIA2300s-DS、pCAMBIA2300s-P12H、pCAMBIA2300s-D6HAnd pCAMBIA2300s-UGTPn20Positive agrobacterium strain of plasmid, and the sequence is identical to the original sequence through sequencing verification, and the strain glycerol is preserved at-80 ℃ for standby.
Example 4: agrobacterium-mediated genetic transformation of tobacco
The transgenic recipient in this experiment was tobacco, tobacco seeds were soaked in 75% ethanol for 30s, washed with sterile water and then washed with 0.1% HgCl2Soaking for 8min, washing with sterile water for several times, sowing on 1/2MS culture medium, dark culturing at 28 deg.C for 6d, germinating, transferring to light incubator (25 deg.C, 16 h/d light), and subculturing with 1/2MS culture medium every monthNext, the process is carried out.
The preserved liquid containing pCAMBIA2300s was taken out from the-80 ℃ refrigeratorDS、pCAMBIA2300s-P12H、pCAMBIA2300s-D6HAnd pCAMBIA2300s-UGTPn20Agrobacterium LBA4404 strain of plasmid, inoculating Agrobacterium containing target gene in LB liquid culture medium containing 50mg/L kanamycin and 20mg/L rifampicin, culturing at 28 deg.C and 200rpm until the culture medium is turbid; sucking 1mL of turbid mixed bacteria liquid to an LB solid culture medium containing 50mg/L kanamycin and 20mg/L rifampicin, and culturing for 48h at 28 ℃; then scraping off the agrobacterium on an LB solid culture medium, inoculating the agrobacterium on an MGL liquid culture medium added with 20mg/L acetosyringone, and carrying out shake culture at 28 ℃ for 2-3h to activate the agrobacterium.
Mixing 1cm2Placing tobacco leaf with size into MGL liquid culture medium containing four target genes Agrobacterium tumefaciens, and shake-culturing at 120rpm and 28 deg.C for 20 min; after infection, sucking the taken bacterial liquid of the tobacco leaves by using sterile filter paper, transferring the bacterial liquid into an MS solid culture medium containing 40mg/L acetosyringone, and performing dark culture for 48 hours at about 25 ℃;
transferring the tobacco leaves after the co-culture to a screening culture medium (MS +0.5 mg/L6-BA +0.1mg/L NAA +50mg/L kanamycin +300 mg/L cephamycin) for selective culture, transferring a culture bottle to a light incubator for culture (25 ℃, 16 h/d light and 8 h/d dark) during the screening culture, carrying out subculture on the tobacco leaves after the tobacco leaves are differentiated and germinated by using an MS culture medium containing 50mg/L kanamycin and 300mg/L cephamycin, wherein the regeneration plants need to be further screened because the callus differentiation rate of the tobacco is higher, transferring the regeneration seedlings of the tobacco to the MS culture medium containing 50mg/L kanamycin to root the regeneration plants, and finally selecting the regeneration seedlings with better rooting for further detection.
Detecting DNA level, extracting DNA of transgenic tobacco leaf by CTAB method, taking genome DNA of transgenic plant as template, and amplifying genePnDDSP12HD6HAndUGTPn20carrying out PCR on the specific primer; the PCR reaction system is 2 μ L DNA, 0.4 μ L upstream primer (10 μ M), 0.4 μ L downstream primer (10 μ M), 10 μ L PCR Mix, 7.2 μ L ddH 2O; and (3) PCR reaction conditions: 5min at 94 ℃; 94 ℃ for 30s, 60 ℃ for 90s, 72 ℃ for 1min, 32 cycles; 7min at 72 ℃; after the PCR is finished, 10 μ L of the product is used for agarose gel electrophoresis to detect positive transgenic plants, the amplification result of part of tobacco transgenic plants is shown in FIG. 3, and 6 positive plants are obtained by detection on the DNA level.
RNA level detection, total RNA is extracted from positive transgenic single plants and young leaves of non-transgenic tobacco (wild type) on DNA level, the method for extracting total RNA is the same as that in example 1, reverse transcription is carried out to generate a first cDNA chain, and the first cDNA chain is used as a template for amplificationPnDDSP12HD6HAndUGTPn20carrying out PCR on specific primers of the genes; the PCR reaction system was 1.5. mu.L LcDNA, 0.4. mu.L of the forward primer (10. mu.M), 0.4. mu.L of the reverse primer (10. mu.M), 10. mu.L of PCR Mix, 7.7. mu.L of ddH2O; and (3) PCR reaction conditions: 5min at 94 ℃; 30s at 94 ℃, 30s at 60 ℃, 90s at 72 ℃ and 32 cycles; 7min at 72 ℃; after the PCR was completed, 10. mu.L of the resulting mixture was subjected to agarose gel electrophoresis, and each transgenic individual was analyzed based on the PCR resultsPnDDSP12HD6HAndUGTPn20expression of four gene transcription levels, after PCR was completed, 10. mu.L of the DNA was subjected to agarose gel electrophoresis, and the results of detection of some individuals were shown in FIG. 4, and co-detected in T4 and T5 transgenic individualsPnDDSP12HD6HAndUGTPn20four genes are expressed in large amounts at the transcriptional level.
Example 5:PnDDSP12HD6HandUGTPn20gene expression for synthesizing ginsenoside F from tobacco1Influence of (2)
Drying and grinding the leaves of the transgenic tobacco, weighing 1.0g of tobacco leaf powder, soaking the tobacco leaf powder in 50mL of methanol for 24 hours, then performing ultrasonic treatment for 60min, extracting saponin in the transgenic tobacco, and detecting the type and content of ginsenoside in the transgenic tobacco by using HPLC; the specific chromatographic conditions are as follows: high performance liquid chromatography (Agilent 1260), chromatographic column GRACE Vision HT C18 HL (250 mm x 4.6 mm, 5 μm), mobile phase acetonitrile (A)/water (B), flow rate of 1.0mL/min, column temperature of 30 ℃, detection wavelength of 203nm, gradient elution (v/v) by acetonitrile (A)/water (B), gradient elution program: 0-20min, 20% acetonitrile; 20-30min, 20% -35% acetonitrile; 30-40min, 35% acetonitrile; 40-50min, 35-40%Acetonitrile; 50-60min, 40-100% acetonitrile; the results are shown in FIG. 5; wherein in T5 plant, ginsenoside F1The content of (a) is the highest and reaches 88.7 mug/g DW (dry weight); small amounts of the precursors dammarenediol (DD), protopanaxadiol (PPD) and protopanaxatriol (PPT) were also detected.
Sequence listing
<110> university of Kunming science
<120> a method for preparing ginsenoside F1
<160> 12
<170> SIPOSequenceListing 1.0
<210> 1
<211> 2310
<212> DNA
<213> Panax notoginseng (Panax notogeng)
<400> 1
atgtggaagc tgaaggttgc tcaaggaaat gatccatatt tgtatagcac taacaacttt 60
gttggcagac aatattggga gtttcagccc gatgctggta ctccagaaga gagggaagag 120
gttgaaaatg cacgcaagga ttatgtaaac aataaaaagc tacatggagt tcatccatgc 180
agtgatatgc tgatgcgcag gcagcttatt aaagaaagtg gaatcgatct cctaagcata 240
ccgccggtga gattagatga aaacgaacaa gtgaactacg atgcagttac aaccgctgtg 300
aagaaagctc ttcgattgaa ccgggcaatt caagcacacg atggtcactg gccagctgaa 360
aatgcaggct ctttacttta tacacctccc cttatcattg ccctatatat cagcggaacg 420
attgacacta ttctgacaaa acaacacaag aaggaactga ttcgcttcgt ttacaaccat 480
caaaatgagg atggtggatg gggatcctat attgaggggc acagcacgat gattgggtca 540
gtacttagct tcgtgatgtt acgtttgcta ggagaaggat tagctgaatc tgatgatgga 600
aatggtgcag ttgagagagg ccggaagtgg atacttgatc atggaggtgc agccagcata 660
ccctcttggg gaaagactta tctagcggtg cttggagtat atgagtggga agggtgcaac 720
ccgctgcccc cagaattctg gcttttccct tcaagttttc cttttcatcc agcaaaaatg 780
tggatctact gccggtgtac ctacatgcca atgtcgtatt tgtatgggaa gagatatcat 840
ggaccaataa ccgatcttgt tttatctttg agacaagaaa tttacaacat tccttatgag 900
cagataaagt ggaatcaaca gcgccataac tgttgcaagg aggatctcta ctaccctcat 960
tcccttgtac aagacctggt ttgggatggt cttcactact ttagtgaacc attcctcaaa 1020
cgttggccct tcaacaaact gcgaaaaaga ggtctaaaaa gagtggttga actaatgcgc 1080
tatggtgcca ccgagaccag attcataacc acaggaaatg gggaaaaagc tttacaaata 1140
atgagttggt gggcagaaga tcccaatggt gatgagttta aacatcacct tgctagaatt 1200
cctgatttct tatggattgc tgaggatgga atgacagtac agagttttgg tagtcaacta 1260
tgggactgta ttcttgctac tcaagcaatt atcgccacca atatggttga agaatacgga 1320
gattctctta agaaggcgca tttcttcatc aaagaatcgc agataaaaga aaatccaaga 1380
ggagacttct taaaaatgtg tcgacagttt actaaaggtg cgtggacttt ctctgatcaa 1440
gatcatggtt gcgttgtctc ggactgcaca gctgaagcac taaagtgcct tctgttactt 1500
tcacaaatgc cacaggacat tgtcggagaa aaacctaagg ttgagcgatt atatgaggct 1560
gtgaatgttc ttctctattt gcagagtcgt gtaagtggtg gcttcgcagt ttgggagcct 1620
ccagttccaa aaccatattt ggagatgttg aatccttcag aaatttttgc agacattgtt 1680
gttgagagag agcacattga atgcactgca tctgtaatca aaggtctgat ggcatttaaa 1740
tgcttgcatc ctgggcatcg tcagaaagag atagaggatt ctgtggcgaa agccatccgt 1800
tatcttgaaa gaaaccaaat gcctgatggt tcatggtatg gcttttgggg aatttgtttc 1860
ctctatggga cattttttac cctatcaggg tttgcttctg ctgggaggac ttatgacaac 1920
agtgaagcag ttcgtaaggg tgttaaattt ttcctttcaa cacaaaatga agaaggtggt 1980
tggggggaga gtcttgaatc atgcccaagc gagaaattta caccactcaa gggaaacagg 2040
acaaatctag tacaaacatc atgggctatg ctaggtctta tgtttggtgg acaggccgag 2100
agagatccga cacctctgca tagagcagcg aagttgttga tcaatgcgca aatggataat 2160
ggagatttcc ctcaacagga aattactgga gtatactgta aaaatagtat gttacattat 2220
gcggagtaca gaaatatatt tcctctttgg gcactcggag aatatcggaa acgtgtttgg 2280
ttgccaaagc accagcagct caaaatttaa 2310
<210> 2
<211> 1503
<212> DNA
<213> Panax notoginseng (Panax notogeng)
<400> 2
atgcacatta cattcaatcc aaccaaaacc ttaggtgata tggcagcagc aatggtgttg 60
tttttctccc tatctcttct tctccttccc cttcccctat tattgtttgc ctatttttct 120
tatacaaaac gcatccccca gaaagaaaat gattcaaaag ctcccctccc ccccggtcaa 180
acaggttggc ctttgatagg cgaaactctt aattatttat cttgtgtcaa aagtgggttt 240
tctgaaaatt ttgtgaaata taggaaggaa aagtattccc ccaaagtttt caggacatct 300
cttttaggag aaccgatggc aatcttgtgt gggccggagg ggaacaaatt cctctactca 360
acggaaaaaa agctagtcca aacttggttc ccgagcagtg ttgaaaagat gttccccaga 420
tctcatggcg aatccaacgc agacaacttc tccaaagtac gcggcaaaat gatgtttcta 480
ctcaaggtgg acgggctgaa aaaatatgtt ggcctaatgg acagggtgat gaaacagttt 540
ttagagacgg attggaatcg ccaacaacaa atcaacgttc acaacacggt taagaaatac 600
acggtcacga tgtcgtgtcg ggtgtttatg agtatcgatg atgaagagca agtcagaaga 660
cttggcagct caattcagaa catagaggcc ggactcctcg ccgtgcctat aaatataccg 720
gggactgcta tgaatcgtgc cattaagacc gtaaagttgc tatctagaga ggttgaggcg 780
gtgattaagc aaagaaaagt ggatcttttg gagaataagc aagcgtccca accgcaagat 840
ttattgtcac acttgctact tacggccaat caggatggcc agtttttgag cgaatcggat 900
attgctagcc acttgatagg cttgatgcaa ggtggttata ccaccttaaa tggtacaatc 960
accttcgtta tcaactatct tgcagagttt cctgatgtct acaatcaagt ccttaaagag 1020
caagtggaaa tagcaaactc aaaacaccca aaagagttgc ttaattggga ggatttgagg 1080
aagatgaagt attcgtggaa tgttgctcaa gaggtattga gaataatacc accaggagtt 1140
ggaacattca gagaggctat taccgacttc acctatgctg gatatttaat tccaaaggga 1200
tggaagatgc atctgattcc acatgacacg cacaagaacc caacatattt tccaaatcca 1260
gaaaaattcg atccaaccag gtttgaagga aatggtccgg ctccatatac atttactcct 1320
ttcggaggag gacctcgaat gtgtccggga attgaatatg cacgtctagt aatactcatt 1380
tttattcaca atgtggttac aaacttcaga tgggagaagc tcatccctag tgaaaaaatt 1440
ctcaccgatc cgattccaag atttgcgcat ggacttccaa ttcatctaca tccccacaat 1500
taa 1503
<210> 3
<211> 1407
<212> DNA
<213> Panax notoginseng (Panax notogeng)
<400> 3
atggatctct ttatctcatc tcaattactt cttctactag tcttttgctt attcctcttt 60
tggaatttca aaccaagtag ccaaaacaaa cttccccccg gcaaaacagg atggcccata 120
attggagaaa cactagaatt catctcctgt ggccaaaaag gtaaccctga aaagttcgta 180
acacaaagaa tgaaaaaata ctcccctgat gtcttcacaa catccttagc aggcgagaaa 240
atggtagttt tctgcggtgc ctyggggaac aaattcwttt tctccaasga aaacaagctt 300
gttgtgtcct ggkggccccc tgccawwtcm aaaatcctaa ctgcaacaat accttcggta 360
gagaaaagca aagccttgcg gagtctaatt gttgaattct taaaacccga agcaytccac 420
aagtttattt cggtcatgga tcggacaacg aggcagcact ttgaagccaa atggaacggg 480
agtacagaag tgaaagcttt cgctatgtca gagacgctga cttttgagtt ggcctgttgg 540
ctgctcttta gcataagtga tccggtgcag gtgcagaagc tttctcatct ttttgagaag 600
gttaaagcgg gattattgtc tttaccttta aactttccgg gcacggcttt taaccgtggg 660
atcaaggccg ccaatcttat tagaaaagag ctttcggtgg tgataaaaca gaggagaagt 720
gataaatcag agactcgaaa ggatcttttg tcccacgtta tgatttccaa tggcgagggc 780
gagaaatttt tcagcgaaat ggatattgcg gacgttgttc ttaatatact gattgctagc 840
catgatacca ctagcagtgc catgggctct gtggtctact ttcttgcaga tcatcctcac 900
atctatgcta aagtcctcac agaacaaatg gagatcgcaa agtcgaaagg ggcaggagaa 960
cttttgagct gggacgacat caagaggatg aagtattccc gcaatgttat aaatgaagct 1020
atgagattag tacctccttc tcaaggaggt tttaaagtag ttacaagtaa attcmgttac 1080
gcmaacttca tcwttcccaa aggatggaar atcttttgga gcgkwwwctc gacacataaa 1140
gatcccaaat actttaaaaa tccagaggag tttgatcctt caagatttga aggagatgga 1200
cctatgccat tcacatttat accatttgga ggaggaccaa ggatgtgccc tgggagtgag 1260
tttgctcgtc tggaggttct aatattcatg caccatttgg ttaccaattt taggtgggag 1320
aaggtgtttc ccaatgaaaa gattatttat actccatccc tcccggagaa tggtcttcct 1380
attcgtctat caccttgtac gctttaa 1407
<210> 4
<211> 1423
<212> DNA
<213> Panax notoginseng (Panax notogeng)
<400> 4
atgaagtcag aattgatatt cttccttacg acggctcgga cacctcgtgg gatggtggag 60
atggctaaac tcttcatcag tcgacatgaa aacctctcgg tcaccgtcct catcgcgaaa 120
ttctacatgg atacgggggt agacaactac aataaatcac tcttaacaaa gcctaccccg 180
cgtctcacaa ttgtaaatct cccggaaagc gacccccaaa actatatgct caaaccacgc 240
cacgccatct ttcctagcgt catcgagact cagaagacac acgtgcgaga cataatatca 300
ggcatgactc agtccgagtc gactcgggtc gttggtttgc tggctgacct tttgttcatc 360
ammmywwtkg rcattgccaa tgagttcaat gttccaactt atgtatactc ccctgccgga 420
gcaggtcaty ttggcctygs gttccatytc cagacactca acgacaaaaa gcaagatgtg 480
accgagttca ggcactcgga cactgagtta ttggtaccga gttttgcaaa cccggttccc 540
gccgaggtct tgccgtcgat gtatgtggat aaagaaggtg ggtatgatta tttgttttca 600
ttgttccgga ggtgcagaga gtcaaaggca attattatta acacgtttga ggagctggaa 660
ccctatgcga tcaattccct ccggatggat agtatgatcc ctccgatcta cccggtggga 720
cccatactaa atctcaacgg tgatggccaa aactccgatg aggctgctgt gatccttggt 780
tggttagacg atcaaccacc ttcatctgtg gtgtttttgt gctttggtag ctatggaacc 840
tttcaagaaa accaggtgaa ggagattgca atgggtctag agcgcagtgg gcatcgcttc 900
ttgtggtcct tgcgtccgtc tatccctaaa ggcgagacaa agcttcagct taaatactca 960
aatttggaag aaattctccc agtcggattc ttggacagga catcatgcgt cggaaaagtt 1020
attggatggg ccccgcaagt ggcggtgcyc gracacgagg cagtcggagg gttcctgtct 1080
cattgtggtt ggaattcgac attagagagt gtgtggtgtg gcgtgcccgt cgcaacatgg 1140
ccaatgtacg gcgagcaaca actcaatgct tttgagatgg ttaaggagtt gggtattgcg 1200
gtggaaattg aggtggacta taagaatgaa tattttaaca tgacgaatga ttttattgtt 1260
agggcagaag aaatcgagac gaaaataaag aagctgatga tggatgaaaa gaatagtgaa 1320
ataaggaaga aggtaaagga aatgaaagaa aagagtaggc ttgcaatgtc tgagaatgga 1380
tcatcttata atcatgacga aggtatttga ggaaattatg taa 1423
<210> 5
<211> 28
<212> DNA
<213> Artificial sequence (Artificial)
<400> 5
gggtacccct gcagatgtgg aagctgaa 28
<210> 6
<211> 34
<212> DNA
<213> Artificial sequence (Artificial)
<400> 6
tgcactgcag tgcacccggg ttaaattttg agct 34
<210> 7
<211> 32
<212> DNA
<213> Artificial sequence (Artificial)
<400> 7
cgagctcgat ggtgttgttt ttctccctat ct 32
<210> 8
<211> 38
<212> DNA
<213> Artificial sequence (Artificial)
<400> 8
tgcactgcag tgcattaatt gtggggatgt agatgaat 38
<210> 9
<211> 29
<212> DNA
<213> Artificial sequence (Artificial)
<400> 9
cgagctcatg gatctcttta tctcatctc 29
<210> 10
<211> 29
<212> DNA
<213> Artificial sequence (Artificial)
<400> 10
cgcggatccc aaggtgatag acgaatagg 29
<210> 11
<211> 25
<212> DNA
<213> Artificial sequence (Artificial)
<400> 11
ggaattccat aaatctggga aaggg 25
<210> 12
<211> 28
<212> DNA
<213> Artificial sequence (Artificial)
<400> 12
cgagctcgcc aacaataaaa tcgtcact 28

Claims (1)

1. Ginsenoside F1The preparation method is characterized by comprising the following steps: the genePnDDSP12HD6HAndUGTPn20simultaneously transferring into tobacco to obtain synthetic ginsenoside F1The transgenic tobacco of (1), wherein the genePnDDSThe nucleotide sequence of (A) is shown as SEQ ID NO. 1, geneP12HThe nucleotide sequence of (A) is shown as SEQ ID NO. 2, geneD6HThe nucleotide sequence of (A) is shown as SEQ ID NO. 3, the geneUGTPn20The nucleotide sequence of (A) is shown in SEQ ID NO. 4.
CN202110895036.0A 2021-08-05 2021-08-05 Preparation method of ginsenoside F1 Active CN113549649B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110895036.0A CN113549649B (en) 2021-08-05 2021-08-05 Preparation method of ginsenoside F1

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110895036.0A CN113549649B (en) 2021-08-05 2021-08-05 Preparation method of ginsenoside F1

Publications (2)

Publication Number Publication Date
CN113549649A CN113549649A (en) 2021-10-26
CN113549649B true CN113549649B (en) 2022-07-01

Family

ID=78105320

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110895036.0A Active CN113549649B (en) 2021-08-05 2021-08-05 Preparation method of ginsenoside F1

Country Status (1)

Country Link
CN (1) CN113549649B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113493795B (en) * 2021-08-03 2022-10-28 昆明理工大学 Preparation method of ginsenoside Rh2
CN115725620B (en) * 2022-09-12 2023-09-15 昆明理工大学 Method for synthesizing panax japonicus saponins in pseudo-ginseng cells
CN116656727B (en) * 2023-06-12 2024-04-16 昆明理工大学 Preparation method of panax japonicus saponin IVa

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110438099A (en) * 2018-05-04 2019-11-12 中国科学院天津工业生物技术研究所 The application of glycosyl transferase and its associated materials in the engineering bacteria that building produces ginsenoside Rb1 and Rg1
CN113493795A (en) * 2021-08-03 2021-10-12 昆明理工大学 Preparation method of ginsenoside Rh2

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10174355B2 (en) * 2014-04-30 2019-01-08 Korea Advanced Institute Of Science And Technology Method for glycosylation of ginsenoside using a glycosyltransferase derived from panax ginseng

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110438099A (en) * 2018-05-04 2019-11-12 中国科学院天津工业生物技术研究所 The application of glycosyl transferase and its associated materials in the engineering bacteria that building produces ginsenoside Rb1 and Rg1
CN113493795A (en) * 2021-08-03 2021-10-12 昆明理工大学 Preparation method of ginsenoside Rh2

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
Enzymatic preparation of ginsenosides Rg2, Rh1, and F1;Ko SR等;《Chem Pharm Bull (Tokyo)》;20030430;第51卷(第4期);404-408 *
Functional regulation of a UDP-glucosyltransferase gene (Pq3-O-UGT1) by RNA interference and overexpression in Panax quinquefolius;Chao Lu等;《Plant Cell》;20170217;第129卷;445–456 *
Liu,M.H.等;Panax notoginseng isolate CL13820Contig1_DS dammarenediol-II syn;《GenBank Database》;20150428;Accession No.KJ804174.1 *
The chromosome-level reference genome assembly for Panax notoginseng and insights into ginsenoside biosynthesis;Jiang Z等;《Plant Commun》;20200920;第2卷(第1期);100113 *
三七总皂苷(PNS)肠溶缓释片制备工艺及体外释放研究;张琳等;《时珍国医国药》;20190420(第04期);99-103 *
人参皂苷生物合成关键酶基因DS与D12H的异源共表达研究;安岩;《中国优秀博硕士学位论文全文数据库(硕士)基础科学辑》;20141015(第10期);A006-48 *
人参皂苷糖基转移酶基因研究概述;林廷文等;《中国中药杂志》;20201231(第19期);44-51 *
生物转化法制备稀有人参皂苷及其生物活性研究;李瑞婷;《中国优秀博硕士学位论文全文数据库(硕士)医药卫生科技辑》;20210515(第05期);E057-112 *
调控三七皂苷生物合成PnERF转录因子的克隆与功能研究;卢荣江;《中国优秀博硕士学位论文全文数据库(硕士)基础科学辑》;20190315(第03期);A006-48 *

Also Published As

Publication number Publication date
CN113549649A (en) 2021-10-26

Similar Documents

Publication Publication Date Title
CN113549649B (en) Preparation method of ginsenoside F1
CN109295080B (en) Application of rhizoma panacis majoris beta-balsamol synthetase gene Pj beta-AS
CN107541520B (en) OsSAUR11 gene related to rice root development and stress resistance, coding protein and application
CN110628808B (en) Arabidopsis AtTCP5 gene and application thereof in regulating plant height
CN113549630B (en) Ginseng PgJAZ1 gene, method for improving protopanaxatriol saponin based on gene and application
CN113493795B (en) Preparation method of ginsenoside Rh2
CN106754957B (en) OsSCAMP13 gene, encoding protein, application of stress resistance and acquisition method
CN115725620B (en) Method for synthesizing panax japonicus saponins in pseudo-ginseng cells
CN110819643A (en) Ginseng PgCYP309 gene and application thereof
CN110656118A (en) Geranium strictipes inulin degrading enzyme gene Tk1-FEH and application thereof
CN116656727B (en) Preparation method of panax japonicus saponin IVa
CN114591969A (en) Drought-resistant gene CrWRKY57 and application thereof in drought-resistant improvement of plants
CN110951771B (en) Chinese cymbidiummiR390aApplication in controlling plant root system development
CN110157714B (en) SafflowerCtXTH1 gene, and coding protein and application thereof
CN113337522A (en) Application of cotton GhNFYC4 gene in promoting plant flowering
CN108588069B (en) Precursor gene of mulberry miR171a and application thereof in enhancing salt tolerance of plants
CN112341531A (en) Rice sugar transport gene OsVGT2, sugar transporter thereof, application thereof and amplification primer
CN116732088B (en) Application of PpyBZR2 gene in promoting pear dormancy bud germination
CN115927280B (en) Horse chestnut 2, 3-oxidation squalene cyclase and encoding gene and application thereof
CN116769797B (en) Application of methyl jasmonate and PpyMYC2 gene in germination
CN115074374B (en) Apple triterpenic acid synthesis key enzyme genes MdTYP 716A2 and MdTYP 716C1 and application thereof
CN113637686B (en) Application of potato StABL1 gene in regulation of potato maturity
CN113584051B (en) Application of GhGAI gene in regulation and control of plant flowering
CN117511970B (en) Coronatine-induced ginseng PgJOX2 gene and application thereof
CN113943741B (en) Gene editing and application of rice quality trait genes

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant